Mehabe score: 2 G Factor: 4 Piotski Score: 5 The stock has a rating HOLD. The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 4 and Piotski score of 5.
Description
HCKK Ventures is a company engaged in the activity of Relty Developers, Trading in Medical Equipment. Site:HCKKVENTURE Main Symbol:HCKKVENTURE
Stock trades at 36.6, below its 50dma 38.59 and below its 200dma 43.51. The stock remains bearish on technicals
The 52 week high is at 40.15 and the 52week low is at 30.10
Price Chart
P/E Chart
Sales and Margin
Strengths
– is almost debt free.
Weakness
– Stock is trading at 3.30 times its book value
– has low interest coverage ratio.
-The company has delivered a poor sales growth of 0.00% over past five years.
– has a low return on equity of -2.13% for last 3 years.
Competition
– The industry trades at a mean P/E of 36.4x. Adani Enterp. trades at the industry’s max P/E of 301.6x. HCKKVENTURE trades at a P/E of x
– Industry’s mean G-Factor is 3.1 while the mean Piotski score is 8.0. HCKKVENTURE has a G-Factor of 4 and Piotski scoreof 5.
– Average 1 month return for industry is 11.2%. The max 1- month return was given by Optiemus Infra.: a return of 34.07 %
Quarterly Results
Sales for period ended Mar 2022 is Rs 0.01 cr compared to Rs 0.02 cr for period ended Mar 2021, a fall of 50.0%
.
.
Company reported negative operating profit of Rs -0.07 cr for period ended Mar 2022. For same period last year, operating profit was -0.07.
The EPS for quarter ended Mar 2022 is Rs -0.11 compared to Rs -0.13 for previous quarter ended Dec 2021 and Rs 0.13 for Mar 2021.
Profit & Loss Statement
Profit&Loss Comments
Company reported sales of Rs 0.09 cr for period ended Mar 2022 vis-vis sales of Rs 0.07 cr for the period ended Mar 2021, a healthy growth of 22.2%. The 3 year sales cagr stood at -39.7%.
Operating margins expanded to -211.11% for period ended Mar 2022 vis-vis -300.0% for period ended Mar 2021, expansion of 8889.0 bps.
Net Profit reported at Rs -0.1 cr for period ended Mar 2022 vis-vis sales of Rs -0.57 cr for the period ended Mar 2021, rising 0%.
Balance Sheet Statement
Cash Flow Statement
Cash Flow comments
Sales Growth
Profit Growth Statement
Profit Growth Statement
Stock Price CAGR
Return of Equity
General Comments
– The stock has given a return of 22% on a 1 Year basis vis-vis a return of -7% over the last 3 Years. – The compounded sales growth on a TTM bassis is 29% vis-vis a compounded sales growth of -40% over the last 3 Years. – The compounded profit growth on a TTM basis is 9% vis-vis a compounded profit growth of % over the last 3 Years.
Ratios
Shareholding Pattern
– Public shareholding has remained largely constant. The Mar 2022 public holding stood at 33.3% vis-vis 33.3% for Dec 2021
Conclusion
– is almost debt free. – Stock is trading at 3.30 times its book value
– has low interest coverage ratio.
-The company has delivered a poor sales growth of 0.00% over past five years.
– has a low return on equity of -2.13% for last 3 years.
The business fundamentals of the stock remain stable. Stronger near term results will build interest in the stock. We suggest to wait for a upturn in business performance.
Technically, the stock remains below its 50 DMA 38.59 and is trading at 36.6. Shows a near term lack of buying interest.
